Featured Research

from universities, journals, and other organizations

Blood Test Takes Step Toward Predicting Alzheimer's Risk

Date:
October 15, 2007
Source:
Stanford University Medical Center
Summary:
One of the most distressing aspects of Alzheimer's disease is the difficulty in determining whether mild memory problems are the beginning of an inevitable mental decline. Researchers have now developed a blood test that is a step toward giving people an answer two to six years in advance of the onset of the disease.

One of the most distressing aspects of Alzheimer's disease is the difficulty in determining whether mild memory problems are the beginning of an inevitable mental decline. Researchers at the Stanford University School of Medicine have developed a blood test that is a step toward giving people an answer two to six years in advance of the onset of the disease.

Related Articles


The test identifies changes in a handful of proteins in blood plasma that cells use to convey messages to one another. The research team discovered a connection between shifts in the cells' dialog and the changes in the brain accompanying Alzheimer's. They found that the blood test could indicate who had Alzheimer's with 90 percent agreement with clinical diagnoses, and could predict the onset of Alzheimer's two to six years before symptoms appeared.

"Just as a psychiatrist can conclude a lot of things by listening to the words of a patient, so by 'listening' to different proteins we are measuring whether something is going wrong in the cells," said Tony Wyss-Coray, PhD, associate professor of neurology and neurological sciences and senior author of the study.

"It's not that the cells are using new words when something goes wrong," said Wyss-Coray. "It's just that some words are much stronger and some are much weaker; the chatter has a different tone."

"I really think it has enormous potential," said Lennart Mucke, MD, director and senior investigator of the Gladstone Institute of Neurological Disease at the University of California-San Francisco, who did not participate in the study. "Most researchers in this field agree that there is an urgent need for better lab tests for Alzheimer's disease, and this study has addressed this need admirably."

Listening to cells' messages may not only lead to the first noninvasive diagnostic test for Alzheimer's; it could also lead to similar discoveries about other disorders by focusing on what cells use to talk to each other, said Wyss-Coray, who is part of the Geriatric Research, Education and Clinical Center at the Veterans Affairs Palo Alto Health Care System.

Currently, the clinical diagnosis for Alzheimer's is one of exclusion - by testing for other causes of memory loss and cognitive declines, such as stroke, tumors and alcoholism. If those conditions are eliminated as causes of memory loss, what remains is Alzheimer's, which is the most common cause of dementia. Even the clinical diagnosis is imperfect, and the only definitive diagnosis is by brain autopsy after a person has died.

According to the Alzheimer's Association, more than 5 million Americans are afflicted with the disease, which robs patients of memory, thinking and the ability to communicate.

The blood-test concept began when Wyss-Coray and Sandip Ray, one of the two first authors of the paper, collaborated to measure levels of 120 different proteins used by cells to communicate to see if any of them could be indicators for Alzheimer's.

At the time the work was done, Ray was an employee of Satoris Inc., a company co-founded by Ray, Wyss-Coray and Yuen So, MD, PhD, professor of neurology and neurological sciences. Wyss-Coray is a consultant for Satoris Inc.

Ray used blood samples from five people diagnosed with Alzheimer's, and compared those to samples from five people who didn't have the disease. He found a number of proteins used for communication that demonstrated striking differences between the two groups.

Markus Britschgi, PhD, a postdoctoral scholar in Wyss-Coray's lab, became intrigued with the idea that proteins used by cells to communicate could be measured in the blood to indicate what is going on in the body - including the brain.

"This study made me realize that we should get away from this image of a brain isolated from the body," said Britschgi, who is also a first author of the paper. "The brain is part of the body and so it's connected in one huge network."

Reaching out to clinics in the United States, as well as Sweden, Poland and Italy, Britschgi obtained a total of 259 archived blood samples from individuals who had symptoms ranging from nothing abnormal to mild cognitive impairment to advanced Alzheimer's. Starting with 120 communication proteins, the team developed an analysis procedure to recognize if there was a pattern seen in Alzheimer's that could be compared with that of people without the condition. They discovered that as few as 18 proteins were sufficient to identify an Alzheimer's-specific pattern.

Among blood samples from 92 individuals who ranged from no symptoms to full dementia, the protein analysis matched the clinical diagnosis 90 percent of the time.

They then asked if they could predict the development of Alzheimer's among 47 people with mild cognitive impairment who had been followed from two to six years. The test - done on blood samples taken several years earlier - flagged 91 percent of the patients who developed Alzheimer's by the end of the follow-up time, as diagnosed by conventional methods.

"Already we have people approaching us at meetings asking if they can give us a vial of their grandfather's blood for testing," said Britschgi. Their findings show that it is possible to use factors in the blood to diagnose and even predict the disease, but, the authors emphasized, it must now be confirmed in other labs.

According to Satoris Inc, the company will develop a commercial Alzheimer's blood test, initially for use in research labs and, if confirmed as reliable, eventually as a clinical diagnostic test upon regulatory approval.

Britschgi and Wyss-Coray are interested in finding out why the cell communication pathways are altered in Alzheimer's. In their study, they determined that the 18 proteins that indicate Alzheimer's are also involved in the production of new blood cells, immune processes and apoptosis, the process of programmed cell death when a cell is no longer needed.

"Our hypothesis is that there is something wrong with the production of certain blood cells, which may be needed to clear that stuff that accumulates in the brain in Alzheimer's disease," said Wyss-Coray. "That makes a lot of sense, and it is very exciting to think of immune cells and molecules interacting with the brain."

Mucke, the director of Gladstone, added, "It will be interesting to find out in clinical trials if the identified disease markers are also useful for monitoring the response of individual patients to therapeutic interventions. That would be tremendous."

Of the 25 authors included on this paper, six other contributors from Stanford are included. They are: Yoshiko Takeda-Uchimura, a research associate in Wyss-Coray's laboratory; Leah Friedman, PhD, senior research scholar in psychiatry and behavioral sciences; William Robinson, MD, PhD, assistant professor of medicine; Jared Tinklenberg, MD, professor of psychiatry and behavioral sciences; Jerome Yesavage, MD, professor of psychiatry and behavioral sciences; and Robert Tibshirani, PhD, professor of health research and policy and of statistics. Tibshirani is also a consultant for Satoris Inc.

The study will appear in the Oct. 15 advance online edition of Nature Medicine.

This study was supported by the John Douglas French Alzheimer's Foundation, the Alzheimer's Association, the U.S. National Institute of Aging and Satoris Inc.


Story Source:

The above story is based on materials provided by Stanford University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Stanford University Medical Center. "Blood Test Takes Step Toward Predicting Alzheimer's Risk." ScienceDaily. ScienceDaily, 15 October 2007. <www.sciencedaily.com/releases/2007/10/071014163700.htm>.
Stanford University Medical Center. (2007, October 15). Blood Test Takes Step Toward Predicting Alzheimer's Risk. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2007/10/071014163700.htm
Stanford University Medical Center. "Blood Test Takes Step Toward Predicting Alzheimer's Risk." ScienceDaily. www.sciencedaily.com/releases/2007/10/071014163700.htm (accessed December 19, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

The Best Tips to Curb Holiday Carbs

The Best Tips to Curb Holiday Carbs

Buzz60 (Dec. 19, 2014) It's hard to resist those delicious but fattening carbs we all crave during the winter months, but there are some ways to stay satisfied without consuming the extra calories. Vanessa Freeman (@VanessaFreeTV) has the details. Video provided by Buzz60
Powered by NewsLook.com
Sierra Leone Bikers Spread the Message to Fight Ebola

Sierra Leone Bikers Spread the Message to Fight Ebola

AFP (Dec. 19, 2014) More than 100 motorcyclists hit the road to spread awareness messages about Ebola. Nearly 7,000 people have now died from the virus, almost all of them in west Africa, according to the World Health Organization. Video provided by AFP
Powered by NewsLook.com
Researchers Test Colombian Village With High Alzheimer's Rates

Researchers Test Colombian Village With High Alzheimer's Rates

AFP (Dec. 19, 2014) In Yarumal, a village in N. Colombia, Alzheimer's has ravaged a disproportionately large number of families. A genetic "curse" that may pave the way for research on how to treat the disease that claims a new victim every four seconds. Duration: 02:42 Video provided by AFP
Powered by NewsLook.com
Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Double-Amputee Becomes First To Move Two Prosthetic Arms With His Mind

Buzz60 (Dec. 19, 2014) A double-amputee makes history by becoming the first person to wear and operate two prosthetic arms using only his mind. Jen Markham has the story. Video provided by Buzz60
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins